MedTrace Logo

Joint Movement to Increase Range of Motion in Knee Joint After Primary Total Knee Arthroplasty

NCT06188091 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 83

Last updated 2025-05-23

No results posted yet for this study

Summary

The goal of this clinical trail is to investigate if specific active exercises, with a certain daily frequency improves the range of motion (ROM) in the knee joint after primary- or revision total knee arthroplasty (TKA)

The main questions it aims to answer are:

* Does it make a difference to the ROM of the knee joint to do specific active exercise 2 times a day compared to 8 times a day in an 18 days period of time
* Analyze if range of motion in the knee joint after TKA has an impact on self-reported activity, pain and physical activity

Participants will be instructed by a physiotherapist to do a specific exercise to improve the flexion of the knee-joint and and other to improve the extension of the knee-joint.

One group will be instructed to do the exercises 2 times a day the other group to do the exercises 8 times a day in total of 18 days

The two groups will be compared to see if there is an effect in ROM and if the effect is significant between the groups if the intervention is done 2 times versus 8 times a day.

Conditions

  • Total Knee Arthroplasty

Interventions

BEHAVIORAL

Exercise

Physiotherapeutic instructions to patients to do active exercise to improve the mobility of knee joint post-surgical

Sponsors & Collaborators

  • Nordsjaellands Hospital

    lead OTHER

Principal Investigators

  • Lisbeth Mogensen, cand.scient. · Quality coordinator

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-29
Primary Completion
2024-04-06
Completion
2024-04-06

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06188091 on ClinicalTrials.gov